Senior Director, Immunoanalytical Science & Technology
Ligand Binding Assay Services
Masood Khan, PhD, joined KCAS in 2010 as Senior Director to build a state-of-the-art Ligand Binding Assay department. He brings more than 30 years of experience in immunoanalytical sciences & technologies and senior management. Dr. Khan received his PhD in biochemistry from Aligarh University in India and has conducted post doctoral studies at the National Institute of Environmental Health Sciences in North Carolina, McGill University and Royal Victoria Hospital in Canada. In 1989 he became one of the founding members of Phoenix International Life Sciences (currently MDS Life Sciences) where he developed and very successfully directed the company’s Ligand-binding Assay (LBA) Bioanalytical department for nine years. Later, he served in executive capacities for several major contract research organizations and pharmaceutical companies, including Covance, NeuroBiotech, Medlmmune and GLP Solutions Inc. Over the past 20 years, Dr. Khan has been extensively involved with the strategic planning and development of GLP-compliant Ligand binding assay businesses. He has organized numerous educational events at the annual meetings of the American Association of Pharmaceutical Sciences (AAPS). He also helped in establishing the LBAB-Focus Group at the AAPS and has co-authored several authoritative reviews on the validation of LBA and biomarker assays. He has more than 100 publications and presentations to his credit.